Mayo Clinic Comprehensive Cancer Center (Florida)

Recent papers from Mayo Clinic Comprehensive Cancer Center (Florida)

1. Explaining Cancer Clinical Trial Willingness: The Relative Roles of Information Empowerment and Interpersonal DiscriminationJournal of Racial and Ethnic Health Disparities · 2026
2. Advancing Representation of LGBTQ+, Black Immigrant, and Rural Communities in Oncology Clinical Trials: Future Considerations.2026
3. Epigenetic heterogeneity in breast tumours informs diagnosis and prognosisNature · 2026
4. Expert Strategies: Controversies in Management of Sinonasal Malignancies—Global Perspectives Through a Mixed Methods ApproachInternational Forum of Allergy & Rhinology · 2026
5. Long-term economic benefits of early cancer detection through enhanced multimodal screening: a modeling study of whole-body MRI and liquid biopsyJournal of Comparative Effectiveness Research · 2026
6. Diagnostic Impact of Integrated Molecular Testing in Nodal T-follicular Helper Cell Lymphoma Mimicking Castleman Disease and Classic Hodgkin Lymphoma: A Report of Two CasesCureus · 2026
7. A Standalone PD-1 Chimeric Switch Receptor T-Cell Platform Expands the Therapeutic Window of PD-L1 Targeting in Solid Tumors2026
8. KRAS in pancreatic cancer: from molecular biology to transformative therapeuticsJournal of Hematology & Oncology · 2026
9. Vision and implementation for the first U.S. carbon ion therapy center part I: Clinical rationale and the need for CIRT in the United StatesJournal of Applied Clinical Medical Physics · 2026
10. Characterizing bone metastases and skeletal‐related events in patients with well‐differentiated neuroendocrine neoplasms utilizing 68 Gallium ‐ DOTATATE positron emission tomographyJournal of Neuroendocrinology · 2026
11. Functional precision genomics identifies transcriptional features of therapeutic response and drug resistance in high-grade gliomasnpj Precision Oncology · 2026
12. Vision and implementation for the first U.S. carbon ion therapy center part II: Design philosophy and clinical implementationJournal of Applied Clinical Medical Physics · 2026
13. Randomized controlled trials of radiation therapy for cutaneous malignancies: a systematic reviewClinical and Translational Radiation Oncology · 2026
14. Geographic disparities and temporal trends in aggressive prostate cancer: a SEER population-based analysis (2004–2022)Cancer Causes & Control · 2026
15. Novel Tool to Predict Primary Tumor Location in the Setting of Metastatic Cancer With Unknown PrimaryJCO Oncology Practice · 2026
16. Global proteomic comparison highlights an extracellular-matrix and basement-membrane program in nonmalignant breast tissue from cancer-free BRCA1/2 carriersJournal of Translational Medicine · 2026
17. Physical Function and Rehabilitation Across the CAR T-Cell Therapy Continuum: A Narrative ReviewPhysiologia · 2026
18. Nivolumab plus relatlimab with platinum-doublet chemotherapy versus nivolumab with platinum-doublet chemotherapy in stage IV or recurrent non-small cell lung cancer: clinical, translational, and patient-reported outcomes results from the phase II RELATIVITY-104 studyAnnals of Oncology · 2026
19. Renal Function Decline After 177 Lu-PSMA-617 Versus Taxane-Based Chemotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Propensity Score AnalysisJournal of Nuclear Medicine · 2026
20. International Consensus Guidelines for Radiation Target Volume Delineation for Skull Base Chordoma—A Particle Therapy Co-operative Group InitiativeInternational Journal of Radiation Oncology*Biology*Physics · 2026